|
CN103351344A
|
|
Novel preparation method of imidafenacin intermediate and refined product thereof
|
|
CN103351329A
|
|
Preparation method of Prucalopride intermediates
|
|
CN103508939A
|
|
Method used for preparing prucalopride intermediate 1-(3-methoxypropyl)-4-piperidinamine
|
|
CN103351380A
|
|
Preparation method of Bilastine
|
|
CN103351300A
|
|
Preparation method of aliskiren intermediate side chain ((s)-methyl-2-bromoisovalerate)
|
|
CN103353492A
|
|
Method of separating and measuring solifenacin succinate raw material and preparation thereof by using liquid chromatography
|
|
CN103364500A
|
|
Method for separating and measuring bilastine raw material and preparation thereof by utilizing liquid chromatography
|
|
CN103353491A
|
|
Method for separating and determining alogliptin benzoate raw material and preparation thereof by liquid chromatography
|
|
CN103356616A
|
|
Bilastine-containing pharmaceutical composition and preparation method thereof
|
|
CN103356506A
|
|
Solid lipid nanoparticles of alendronate sodium and preparation method thereof
|
|
CN103222966A
|
|
Solid pharmaceutical composition containing Fingolimod hydrochloride and preparation method thereof
|
|
CN103207245A
|
|
Method of separating and determining dutasteride intermediate and optical isomers thereof by using liquid chromatography
|
|
CN103207246A
|
|
Method of separating and determining lurasidone and optical isomers thereof by using liquid chromatography
|
|
CN103207247A
|
|
Method of separating and determining aliskiren intermediate and optical isomers thereof by using liquid chromatography
|
|
CN103207248A
|
|
Method of separating optical isomers of ezetimibe intermediate by using HPLC
|
|
CN102866222A
|
|
Method for separating and determining duloxetine midbody and optical isomer thereof by utilizing liquid chromatography
|
|
CN102854274A
|
|
Method for separating and determining ezetimibe raw material and preparation thereof by using liquid chromatography method
|
|
CN102850273A
|
|
Novel synthesizing method of (R)-alpha-amino-epsilon-caprolactam
|
|
CN102850244A
|
|
Preparation method for 3-(3-phenylsulfamoyl-phenyl)-acrylic acid
|
|
CN102854273A
|
|
Method for separation determination of duloxetine raw material and preparation thereof by using liquid chromatography method
|
